𝗞𝗻𝗼𝘄 𝗬𝗼𝘂𝗿 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿: 𝗕𝗩𝗙 𝗣𝗮𝗿𝘁𝗻𝗲𝗿𝘀 𝗟.𝗣. In the September Edition of our Know Your Investor Report, we present a condensed yet enlightening analysis of BVF Partners, the leading equity hedge fund manager! In 2023, BVF Partners added 20 companies to its portfolio by investing around $1.52B in six funding rounds. For a PDF copy of this informative report, reach out to us at [email protected] Happy Reading & Stay Tuned! Mirum Pharmaceuticals, Inc., Nimbus Therapeutics, Septerna, PharmaShots #Knowyourinvestor, #BiotechnologyInvesting, #SmallCapStocks, #EarlyStageInvestments, #InvestmentRounds, #BVFPartners, #PortfolioManagement, #BiotechFunding, #InvestmentReport, #PharmaShots, #VentureCapital, #BiotechCompanies, #InvestmentStrategy, #HedgeFunds, #BiotechSector #MirumPharmaceuticals, #NimbusTherapeutics, #Septerna
PharmaShots
Online Audio and Video Media
Uttar Pradesh, UP 10,226 followers
Incisive news in 3 shots
About us
PharmaShots Media: Your Premier Source for Pharma, Biotech, and MedTech Insights Looking for comprehensive and concise updates from the pharmaceutical, biotech, MedTech, digital health, and life sciences industry? Look no further than PharmaShots. We specialize in delivering summarized news, top trends, and valuable insights, keeping you at the forefront of the latest developments. At PharmaShots, we go beyond just reporting the news. Our team conducts exclusive interviews with key opinion leaders (KOLs), providing you with firsthand perspectives and expert opinions. Additionally, we offer comprehensive coverage of conferences and events, ensuring you never miss out on the industry's important discussions and breakthroughs. In addition to our information-packed content, we provide targeted news alert services, allowing you to receive customized updates tailored to your specific interests and needs. We understand the importance of digital marketing in today's competitive landscape, which is why we offer digital marketing solutions to help your brand reach its target audience effectively. Our online advertising and promotional services further enable you to amplify your presence and engage with industry professionals. Originally established as a media product under Octavus Consulting, PharmaShots has now spun out as an independent entity, PharmaShots Media Private Limited. We are dedicated to serving the life sciences industry by delivering high-quality, timely, and actionable information that empowers professionals like you. For more information about our offerings and how PharmaShots can support your business, please reach out to us at [email protected]. Join us in staying ahead of the curve and making informed decisions in the ever-evolving world of healthcare and life sciences.
- Website
-
https://pharmashots.com
External link for PharmaShots
- Industry
- Online Audio and Video Media
- Company size
- 2-10 employees
- Headquarters
- Uttar Pradesh, UP
- Type
- Privately Held
- Founded
- 2018
- Specialties
- Biotech, MedTech, Digital health, Pharmaceuticals, News, Analysis, Summary, Biosimilars, Conference, Reports, Medical Devices, M&A, Cell & Gene Therapy, Generics, Life Sciences, HealthIT, Newswire, Digital Marketing, Content Writing, and KOL Interview
Locations
-
Primary
Get directions
Noida
Uttar Pradesh, UP 201301, IN
-
Get directions
New Delhi, Delhi 110075, IN
Employees at PharmaShots
Updates
-
Know Your Investor: BVF Partners In the September Edition of our Know Your Investor Report, we bring a condensed yet enlightening analysis of the leading equity hedge fund manager company BVF Partners! In 2023, BVF Partners added 20 companies to its portfolio by investing around $1.52B in six funding rounds. For a PDF copy of this informative report, reach out to us at [email protected] Happy Reading & Stay Tuned! #equityhedgefund #biotechnologyinvesting #smallcapstocks #earlystageinvestments #investmentrounds #bvfpartners #portfoliomanagement #biotechfunding #investmentreport #pharmashots #venturecapital #biotechcompanies #investmentstrategy #hedgefunds #biotechsector
Know Your Investor: BVF Partners L.P.
PharmaShots on LinkedIn
-
OncoC4, Inc. Reports the First Patient Dosing in P-I Study of ONC-841 for Solid Tumors #oncoc4 #onc841 #solidtumors #clinicaltrial #firstpatientdosing #phase1 #monoclonalantibody #phagocytosis
OncoC4 Reports the First Patient Dosing in P-I Study of ONC-841 for Solid Tumors
pharmashots.com
-
ALX Oncology Doses the First Patient Under P-I/II (UMBRELLA) Study of Evorpacept Plus Sarclisa for Treating R/R Multiple Myeloma (RRMM) #alxoncology #evorpacept #sarclisa #multiplemyeloma #clinicaltrial #firstpatientdosing #phase1/2 #umbrella #collaboration
ALX Oncology Reports the First Patient Dosing in P-I/II (UMBRELLA) Trial of Evorpacept Plus Sarclisa for Treating R/R Multiple Myeloma (RRMM)
pharmashots.com
-
The EC Grants Orphan Drug Designation to Vivet Therapeutics’ VTX-806 to Treat Cerebrotendinous Xanthomatosis (CTX) #vivettherapeutics #vtx806 #cerebrotendinousxanthomatosis #regulatory #ec #orphandrugdesignation #hepatomegaly #usfda
Vivet Therapeutics’ VTX-806 Receives the EC’s Orphan Drug Designation for Cerebrotendinous Xanthomatosis (CTX)
pharmashots.com
-
HAYA Therapeutics and Eli Lilly and Company Join Forces to Discover Novel Regulatory Genome Targets for Obesity and Other Metabolic Conditions #hayatherapeutics #elililly #obesity #biotech #drugdiscovery #metabolicdisorders #lncrnatargets #obesitydrugs
HAYA Therapeutics and Eli Lilly Partner to Discover Novel Regulatory Genome Targets for Obesity and Other Metabolic Conditions
pharmashots.com
-
Viz.ai Teams Up with Addario Lung Cancer Medical Institute (ALCMI) to Integrate AI into Lung Cancer Detection #viz.ai #addariolungcancermedicalinstitute #digihealth #ai #lungcancerdetection #patientengagement #research #treatment
Viz.ai Collaborates with Addario Lung Cancer Medical Institute (ALCMI) to Integrate AI into Lung Cancer Detection
pharmashots.com
-
Abbott Begins the TRANSCEND Trial of Deep Brain Stimulation System to Manage Severe Depression #abbott #deepbrainstimulationsystem #treatmentresistantdepression #medtech #transcend #usfda #breakthroughdevice
Abbott Reports the Initiation of TRANSCEND Trial Assessing Deep Brain Stimulation System to Manage Severe Depression (TRD)
pharmashots.com
-
EpimAb Biotherapeutics, Inc. Collaborates with Vignette Bio Partner to Develop EMB-06 for Autoimmune Disorders #epimabbiotherapeutics #vignettebio #emb06 #autoimmunedisorders #pharma #collaboration #partnership #agreement #greaterchina #development #commercialization
EpimAb Biotherapeutics and Vignette Bio Partner to Develop EMB-06 for Autoimmune Disorders
pharmashots.com
-
Merck and EyeBio Begin the P-IIb/III (BRUNELLO) Trial of Restoret to Treat Diabetic Macular Edema #merck #eyebio #restoret #diabeticmacularedema #clinicaltrial #brunello #neovascularagerelatedmaculardegeneration #ranibizumab
Merck Commences P-IIb/III (BRUNELLO) Clinical Evaluation of Restoret to Treat Diabetic Macular Edema (DME)
pharmashots.com